Purchases and Sales Made in Q1 2023 in Biondvax Pharmaceuticals Ltd. (BVXVZZZZ)
This table provides information about the institutional ownership of Biondvax Pharmaceuticals Ltd. (BVXVZZZZ) during Q1 2023. The information is specifically focused on institutions that hold shares of BIONDVAX PHARMACEUTICALS LTD. .
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
105K+ 47.79% |
N/A
|
326K
$0
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
43.6KNew |
N/A
|
43.6K
$0
|
|
|
May 01, 2023
Q1 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
10.5KNew |
N/A
|
10.5K
$0
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
- |
5.02K+ 1674.0% |
N/A
|
5.32K
$0
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-250- 98.43% |
N/A
|
4
$0
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-561- 19.91% |
N/A
|
2.26K
$0
|